BNET Industries
Market Cap:$44.7M
Last Fiscal Year Sales:$10.0K
- Public
- US
Dow Jones Description
Northwest Biotherapeutics, Inc. is a development stage biotechnology company focused on discovering, developing and commercializing immunotherapy products that generate and enhance immune system responses to treat cancer. Currently approved cancer treatments are frequently ineffective, can cause undesirable side effects and provide marginal clinical benefits. The Company?s approach in developing cancer therapies utilizes its expertise in the biology of dendritic cells, which are a type of white blood cell that activate the immune system. The Company?s cancer therapies have been demonstrated in clinical trials to significantly extend both time to recurrence and survival, whilst providing a superior quality of life with no debilitating side effects when compared with current therapies.
President, Chief Operating and Scientific Officer
Alton L BoyntonNumber of Employees 2
Peer Companies
NAICS Code Pharmaceutical Preparation Manufacturing: 325412
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Alton L Boynton | President, Chief Operating and Scientific Officer |
| Marnix Bosch | Vice President of Vaccine Research and Development |
| Larry L Richards | Controller |
| Wayne L. Pines | Director |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| Randall L.W. Caudill | Board of Directors |
Dr. Boynton co-founded our company and has served as Secretary since August 2001. He has also served as our Executive Vice President since July 2000, our Chief Scientific Officer and a director since our inception in 1996, and was appointed our Chief Operating Officer in August 2001. In May 2003, Dr. Boynton was appointed President of Northwest Biotherapeutics. Dr. Boynton has also served as Director of the Department of Molecular Medicine of Northwest Hospital from 1995-2003 where he coordinated the establishment of a program centered on carcinogenesis. Prior to moving to Seattle, Dr. Boynton was Associate Director of the Cancer Research Center of Hawaii, The University of Hawaii where he also held the positions of Director of Molecular Oncology of the Cancer Research Center and Professor of Genetics and Molecular Biology. Dr. Boynton received his Ph.D. in Radiation Biology from the University of Iowa in 1972.
| Organization | Position | Status |
|---|---|---|
| Northwest Biotherapeutics, Inc. | President, Chief Operating and Scientific Officer | Current |
| Northwest Biotherapeutics, Inc. | Secretary | Current |
| Northwest Biotherapeutics, Inc. | Executive Vice President | Former |
| Cancer Research Center | Director | Former |
| University of Hawaii | Director | Former |
| The University of Iowa | Ph.D. In Radiation Biology | Former |
Dr. Bosch joined Northwest Biotherapeutics in 2000, and has served as our Vice President for Vaccine R&D since July 2001. Prior to joining us, Dr. Bosch was a member of the faculty of the Department of Pathobiology at the University of Washington, and he continues to serve that Department as an Affiliate Associate Professor. Dr. Bosch obtained his Ph.D. in Medicine at the University of Leiden, the Netherlands in 1987, and his M.B.A. at the University of Washington in 2003.
| Organization | Position | Status |
|---|---|---|
| Northwest Biotherapeutics, Inc. | Vice President of Vaccine Research and Development | Current |
| University of Washington | Faculty Department of Pathobiology | Former |
| University of Leiden | Ph.D. In Medicine | Former |
| University of Washington | M.B.A. | Former |
| Organization | Position | Status |
|---|---|---|
| Northwest Biotherapeutics, Inc. | Controller | Current |
| Organization | Position | Status |
|---|---|---|
| VaxGen, Inc. | Board of Directors | Current |
| Northwest Biotherapeutics, Inc. | Board of Directors | Current |
| Scolr Pharma, Inc. | Member of the Board | Current |
| Helix Biomedix, Inc. | Board of Directors | Current |
| The First Boston Corporation | vice president | Former |
| Morgan Grenfell | Executive Director | Former |
| Pru-One Inc. | co-head | Former |
| Morgan Grenfell | Co-Head of Mergers and Acquisitions | Former |
| University of Oxford | doctorate of philosophy while a Rhodes Scholar | Former |
| Yale University | Master's Degree In Public and Private Management | Former |
| Organization | Position | Status |
|---|---|---|
| The Patient Channel | President, Regulatory Services and Health Care, Employer: Apco Worldwide | Current |
| APCO Worldwide | President | Current |
| Exceltrials, Inc. | Consultant | Current |
| K Street Associates LLC | Consultant | Current |
| Scientific Advantage, LLC | Senior Regulatory Counselor | Current |
| Medstar Research Institute | Chairman of the Board | Current |
| The Patient Channel | Board of Directors | Current |
| Scolr Pharma, Inc. | Board of Directors | Current |
| Exceltrials, Inc. | Board of Directors | Current |
| Clinlaw | Board of Directors | Current |
| Northwest Biotherapeutics, Inc. | Director | Current |
| Public Affairs LLC | Chief of Press Relations | Former |
| Fda.Com | Chief of Press Relations | Former |
| Burson-Marsteller | Executive Vice President | Former |
| Public Affairs LLC | Associate Commissioner | Former |
| Rutgers University | Former |
Industry Transcripts by Seeking Alpha
-
Avanir Pharmaceuticals F4Q09 (Qtr End 09/30/2009) Earnings Call Transcript
on Nov 24, 2009about AVNR
-
Palatin Technologies F1Q10 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 16, 2009about PTN
-
Flamel Technologies SA Q3 2009 Earnings Call Transcript
on Nov 16, 2009about FLML
-
NexMed Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about NEXM
-
InterMune, Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about ITMN
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- Teva, In Turnabout, Sues to Protect Its Multiple Sclerosis Drug Copaxone 3 votes
- Fired Whistleblower Reps Make Similar Claim: Pfizer Said They Lacked "Integrity" 3 votes
- Biogen Idec's Social Media Ties Save Tysabri Again; FDA Watching 3 votes
- VeriChip TV Ad Confirms Critics' Fears: They Want Everyone Implanted 3 votes


